SYNCOM FORMULATIONS (INDIA)
Back to Balance Sheet
|
SYNCOM FORMULATIONS (INDIA) Last 5 Year Contingent Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2017 | Mar2016 | |
---|---|---|---|---|---|
Contingent Liabilities | ₹0.55 Cr | ₹0.55 Cr | ₹0.55 Cr | ₹2.74 Cr | ₹0.83 Cr |
What is the latest Contingent Liabilities ratio of SYNCOM FORMULATIONS (INDIA) ?
Year | Contingent Liabilities |
---|---|
Mar2024 | ₹0.55 Cr |
Mar2023 | ₹0.55 Cr |
Mar2022 | ₹0.55 Cr |
Mar2017 | ₹2.74 Cr |
Mar2016 | ₹0.83 Cr |
How is Contingent Liabilities of SYNCOM FORMULATIONS (INDIA) Trending?
Years | Contingent Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹0.55 Cr | 0.00 | |
Mar2023 | ₹0.55 Cr | 0.00 | |
Mar2022 | ₹0.55 Cr | -79.96 | |
Mar2017 | ₹2.74 Cr | 231.80 | |
Mar2016 | ₹0.83 Cr | - |
Compare Contingent Liabilities of peers of SYNCOM FORMULATIONS (INDIA)
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
SYNCOM FORMULATIONS (INDIA) | ₹1,755.9 Cr | -13.1% | -6.7% | 53.7% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹395,254.0 Cr | -2.5% | -4.9% | 8.7% | Stock Analytics | |
DIVIS LABORATORIES | ₹172,374.0 Cr | -2.7% | -0.9% | 42.5% | Stock Analytics | |
CIPLA | ₹119,795.0 Cr | -1.5% | 0.1% | -4.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹110,698.0 Cr | -2.6% | 8.3% | 7.9% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹107,218.0 Cr | -2.6% | -3.7% | 11.9% | Stock Analytics |
SYNCOM FORMULATIONS (INDIA) Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
SYNCOM FORMULATIONS (INDIA) | -13.1% |
-6.7% |
53.7% |
SENSEX | -0.4% |
0.2% |
5.9% |
You may also like the below Video Courses